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Breastfeeding women often need to take medicines, and therefore health professionals need to consider the
effects of medication on lactation and the breastfed infant, and any associated risks. This commentary discusses
the tragic case of a young woman with a history of mental illness who committed suicide in the postpartum
period. She was determined to be a 'good mother' and breastfeed, and to avoid any potential adverse effects
of medication on her breastfed infant. The final outcome was fatal for both mother and child. We argue that if
women require medication during lactation, all risks need to be considered – the risk of not treating the maternal
medical condition may greatly outweigh the potential risk to the breastfed infant.
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The death of the brilliant and empathetic young UK
psychiatrist who committed suicide in 2000 can have
a positive impact on maternal and child health if we
learn from the family tragedy [1]. An editorial in The
Psychiatrist describing the obstacles experienced by
medical professionals seeking and receiving help for
mental illness has highlighted this case again [2].
The North East London NHS report on the extended
suicide of Dr Daksha Emson, and her three month old
daughter, Freya, describes her history of bipolar affective
disorder and itemises the potential factors that contribu-
ted to the disastrous outcome: immigration, racism,
childhood sexual abuse, stigma of mental illness, being a
doctor and a patient, and the stresses of pregnancy
losses and the postpartum period [3]. She had overcome
many obstacles in order to establish her medical career;
at times, alternating between hospital admissions and
academic prizes.
Dr Emson had stopped her medications when planning
a pregnancy, and was reluctant to restart postpartum as
she was keen to breastfeed her daughter.* Correspondence: l.amir@latrobe.edu.au
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reproduction in any medium, provided the or“Being a good mother by breastfeeding Freya, as
Daksha saw it, took such precedence over the need
for treatment of her mental illness that she put her
mental health at risk. There is a great deal of
ignorance about breastfeeding and bipolar affective
disorder on the part of professionals and conflicting
views by expert witnesses about whether it is safe to
breastfeed in conjunction with a mood stabiliser such
as lithium carbonate.” [3 p. 19] (our emphasis).
We shall never know if this double tragedy could have
been averted if Dr Emson had been more closely moni-
tored in the risky postpartum period, and if she had
recommenced lithium treatment. In the past, lithium
was regarded as one of the few medicines contraindi-
cated for breastfeeding women [4]. It was thought the
risk to the breastfed infant was too high.
Today, however, clinicians are looking more closely at
the compatibility of medicines such as lithium and
breastfeeding. Recent guidelines from beyondblue in
Australia state that “If the woman chooses to breastfeed,
lithium should be used with particular caution. The
decision should be made in consultation with a specialist
physician and, where possible, there should be ongoing
specialist monitoring for potential adverse effects on
the breastfed infant." [5 p. 56]. Case series have shownd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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previously thought, and if infants’ plasma concentrations
are monitored, continued breastfeeding is possible in
selected women [6,7]. Debra Bogen and colleagues have
reported three cases of women who successfully breast-
fed while maintaining lithium treatment [8]. If a woman
wishes to breastfeed during lithium therapy, the neonate
must be closely observed for dehydration, tremor, invol-
untary movements, cyanosis, muscle tone and other
adverse effects, and monitored by blood tests for lithium
concentrations [6,7]. Supplementary formula feeds should
be available in case toxicity is suspected.
The ‘good mother’ discourse asserts that good mothers
will breastfeed and avoid any possible contaminants
entering their bodies or their breast milk [9]. Health
professionals need to challenge this assertion. Good
mothers need to look after their own health first, and
not compromise their treatment options. Evidence
shows that women with mental illnesses are not able to
function optimally [5], yet are cautious about taking
medicines while breastfeeding because of fear about the
effects on their infant or on their ability to breastfeed
[10,11].
The majority of breastfeeding women do take medica-
tion [12,13], as women face both acute illnesses and
ongoing medical conditions in the postpartum period.
However, the impact on breastfeeding rates, breastfeeding
success and infants’ outcomes is largely unknown [14-18].
To advise women about the compatibility of medicines
and breastfeeding, health professionals need access to
accurate information [19]. Information from pharma-
ceutical companies is usually unnecessarily cautious and
should not be relied on. Although more research is
urgently needed, clinicians can access information elec-
tronically through LactMed [20] and the Perinatal Psy-
chotropic Medicine Information Service [21], as well
from information services and books [22-24]. Larger
studies and long-term follow-up data on child health
and school performance, which we are currently lacking,
are needed to improve advice for parents [17,25-28].
Another factor limiting clinicians' decision-making about
medicines in lactation is that it is almost impossible to
access measurement of drug levels in maternal milk or
infant blood. Real time access to measurement of drug
levels in clinical laboratories would facilitate evidence-
based decisions.
Women and their families need to be aware that
depression and anxiety are common in the postpartum
period. Women may not realise that feelings of exhaus-
tion, sadness, anxiety, loss of appetite and difficulty
sleeping may be symptoms of depression and related
conditions [5]. Health professionals should discuss these
issues with new mothers and offer information, support
and treatment options.Most medicines are safe for breastfeeding women as
the breastfed infant would receive less than 3% of a thera-
peutic dose per kilogram of body weight [25 p. 617], and
many medicines are prescribed for neonates themselves.
When the decision is not straightforward, clinicians need
to consult experienced pharmacists before concluding
that breastfeeding and medicine use is too risky. Most
decisions won’t be as difficult as prescribing lithium in
the peripartum period, but Dr Daksha Emson’s tragic case
should teach us that failing to prescribe medicine for a
breastfeeding woman could be fatal for both mother and
child.
Competing interests
The authors declare they have no competing interests.
Authors' contributions
LHA wrote the first draft of the paper. The other authors revised the paper
with additional intellectual input. All authors approved the final version.
Acknowledgements
LHA has an Australian National Health and Medical Research Council Career
Development Fellowship.
Author details
1Mother & Child Health Research, La Trobe University, Melbourne, VIC,
Australia. 2School of Nursing and Midwifery, La Trobe University, Bundoora,
VIC, Australia. 3Department of Nursing, College of Human and Health
Sciences, Swansea University, Swansea, Wales, UK.
Received: 27 September 2012 Accepted: 15 October 2012
Published: 17 October 2012
References
1. Emson D: Obitury: Daksha Emson: Formerly Specialist Registrar
community and rehabilitation psychiatrist Oxleas NHS Trust, died
tragically 27 October 2000. Psychiatrist 2004, 28:152.
2. Garelick AI: Doctors’ health: stigma and the professional discomfort in
seeking help. Psychiatrist 2012, 36:81–84.
3. Report of an independent inquiry into the care and treatment of Daksha
Emson M.B.B.S., MRCPsych, MSc. and her daughter Freya. North East London:
NHS; 2003.
4. Committee on Drugs, American Academy of Pediatrics: The transfer
of drugs and other chemicals into human milk. Pediatrics 1994,
93(1):137–150.
5. Austin M-P, Highet N, Guidelines Expert Advisory Committee: Clinical
Practice Guidelines for Depression and Related Disorders - Anxiety, Bipolar
Disorder and Puerperal Psychosis - in the Perinatal Periodcp A Guideline for
Primary Care Professionals. I. Melbourne: beyondblue: the national
depression initiative; 2011.
6. Viguera AC, Newport DJ, Ritchie J, Stowe Z, Whitfield T, Mogielnicki J,
Baldessarini RJ, Zurick A, Cohen LS: Lithium in breast milk and nursing
infants: clinical implications. Am J Psychiatry 2007, 164(2):342–345.
7. Moretti ME, Koren G, Verjee Z, Ito S: Monitoring lithium in breast milk: an
individualized approach for breast-feeding mothers. Ther Drug Monit
2003, 25(3):364–366.
8. Bogen DL, Sit D, Genovese A, Wisner KL: Three cases of lithium exposure
and exclusive breastfeeding. Arch Womens Ment Health 2012, 15(1):69–72.
9. McDonald K, Amir LH, Davey M-A: Maternal bodies and medicines: a
commentary on risk and decision-making of pregnant and breastfeeding
women and health professionals. BMC Publ Health 2011, 11(Suppl 5):S5.
10. Ugarriza DN: Postpartum depressed women's explanation of depression.
J Nurs Scholarsh 2002, 34(3):227–233.
11. Boath E, Bradley E, Henshaw C: Women's views of antidepressants in the
treatment of postnatal depression. J Psychosom Obstet Gynaecol 2004,
25(3–4):221–233.
Amir et al. International Breastfeeding Journal 2012, 7:14 Page 3 of 3
http://www.internationalbreastfeedingjournal.com/content/7/1/1412. Schirm E, Schwagermann MP, Tobi H, den Berg LT d J-v: Drug use during
breastfeeding. A survey from the Netherlands. Eur J Clin Nutr 2004,
58(2):386–390.
13. Matheson I, Kristensen K, Lunde PKM: Drug utilization in breast-feeding
women. A survey in Oslo. Eur J Clin Pharmacol 1990, 38:453–459.
14. Gendron MP, Martin B, Oraichi D, Berard A: Health care providers' requests
to Teratogen Information Services on medication use during pregnancy
and lactation. Eur J Clin Pharmacol 2009, 65(5):523–531.
15. Chaves RG, Lamounier JA, César CC: Self-medication in nursing mothers
and its influence on the duration of breastfeeding. J Pediatr (Rio J) 2009,
85(2):129–134.
16. Friguls B, Joya X, Garcia-Algar O, Pallas CR, Vall O, Pichini S: A
comprehensive review of assay methods to determine drugs in breast
milk and the safety of breastfeeding when taking drugs. Anal Bioanal
Chem 2010, 397(3):1157–1179.
17. Menon SJ: Psychotropic medication during pregnancy and lactation.
Arch Gynecol Obstet 2008, 277(1):1–13.
18. Chaves RG, Lamounier JA, Cesar CC: Association between duration of
breastfeeding and drug therapy. Asian Pac J Trop Dis 2011, 1(3):216–221.
19. Amir LH: Medicines and breastfeeding: information is available on safe
use (Letter). Med J Aust 2007, 186(9):485.
20. Drugs and Lactation Database (LactMed). http://toxnet.nlm.nih.gov/cgi-bin/
sis/htmlgen?LACT.
21. Perinatal Psychotropic Medicine Information Service (PPMIS).
http://www.ppmis.org.au/.
22. Hale T: Medications and Mothers' Milk. 13th edition. Amarillo, Texas: Hale
Publishing L. P; 2008.
23. Koren G: Medication Safety in Pregnancy & Breastfeeding: The Evidence-Based
A-to-Z Clinician's Pocket Guide. New York: McGraw Hill; 2007.
24. Loke YC: Pregnancy and Breastfeeding Medicines Guide. Melbourne, Australia:
The Royal Women's Hospital, Pharmacy Department; 2010.
25. Lawrence R, Schaefer C: General commentary on drug therapy and drug
risk during lactation. In Drugs During Pregnancy and Lactation: Treatment
Options and Risk Assessment. 2nd edition. Edited by Schaefer C, Peters P,
Miller RK. London: Elsevier; 2007:609–620.
26. Pearlstein T, Howard M, Salisbury A, Zlotnick C: Postpartum depression.
Am J Obstet Gynecol 2009, 200(4):357–364.
27. di Scalea TL, Wisner KL: Pharmacotherapy of postpartum depression.
Expert Opin Pharmacother 2009, 10(16):2593–2607.
28. Hale TW, Kendall-Tackett K, Cong Z, Votta R, McCurdy F: Discontinuation
syndrome in newborns whose mothers took antidepressants while
pregnant or breastfeeding. Breastfeed Med 2010, 5(6):283–288.
doi:10.1186/1746-4358-7-14
Cite this article as: Amir et al.: Avoiding risk at what cost? Putting use
of medicines for breastfeeding women into perspective. International
Breastfeeding Journal 2012 7:14.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
